Related Experiment Video
Updated: Apr 1, 2026

07:30
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
3.5K
Cortical tau load is associated with white matter hyperintensities
Kirsty E McAleese1, Michael Firbank2, Madhurima Dey2
1Institute of Neuroscience, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, UK. Kirsty.McAleese@ncl.ac.uk.
Acta Neuropathologica Communications
|October 1, 2015
Summary
Alzheimer's disease (AD) brain pathology, specifically hyperphosphorylated tau (HPτ), independently predicts white matter lesion (WML) severity. This suggests WMLs in AD patients may signal tau pathology rather than small vessel disease.
Area of Science:
- Neuroscience
- Neuropathology
- Radiology
Background:
- Cerebral white matter lesions (WMLs), or white matter hyperintensities (WMH), are linked to small vessel disease (SVD).
- Alternatively, WMH may result from axonal damage secondary to Alzheimer's disease (AD) pathologies like hyperphosphorylated tau (HPτ) and amyloid-beta (Aβ).
Purpose of the Study:
- To investigate the independent contributions of HPτ, Aβ, and SVD to the severity of WMH.
- To determine if WMH in AD patients are primarily associated with AD pathology or SVD.
Main Methods:
- Post-mortem MRI of 36 human cerebral hemispheres assessed WMH using the Age Related White Matter Change scale (ARWMC).
- Quantitative assessment of cortical HPτ and Aβ burden (using AT8 and 4G8 immunoreactivity) and WM SVD severity (sclerotic index).
- Statistical comparison of ARWMC scores with HPτ, Aβ, and SVD markers in AD cases versus controls.
Main Results:
- AD cases showed higher HPτ, Aβ, and WMH scores than controls; SVD severity was similar.
- WMH scores correlated with HPτ, Aβ, and SVD markers.
- Linear regression identified cortical HPτ burden as the sole independent predictor of WMH severity.
Conclusions:
- Elevated cortical HPτ burden independently predicts WMH severity, highlighting its role in white matter damage pathogenesis.
- WMH in AD patients may reflect underlying cortical AD pathology, not solely SVD.
- Further research is needed to understand WMH pathogenesis and its potential as a biomarker for AD-associated pathology.

